Additional file 2 of The Prostate cancer–Exercise and Metformin randomised controlled feasibility Trial (Pre-EMpT) in men following active surveillance, radical prostatectomy and radiotherapy

Additional file 2: Supplementary Table S1. Secondary outcome measures completed 7-weeks and 4.5 months post-randomisation by men treated with radical prostatectomy and radiotherapy, respectively. Supplementary Table S2. Questionnaire completion rates at each time point. Supplementary Table S3. Baseline secondary outcomes. Supplementary Table S4. Secondary outcomes at 3 months post-randomisation. Supplementary Table S5. Secondary outcomes at 12 months post-randomisation.